domingo, 15 de abril de 2018

Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Screening (PDQ®)—Health Professional Version - National Cancer Institute

Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Screening (PDQ®)—Health Professional Version - National Cancer Institute

National Cancer Institute



Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Screening (PDQ®)–Health Professional Version





SECTIONS



Changes to This Summary (04/06/2018)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
Updated statistics with estimated new cases and deaths for 2018 (cited American Cancer Society as reference 1). Also revised text to state that from 2005 to 2014, incidence rates decreased by 1.4% per year in white women but were stable in African American women; from 2006 to 2015, mortality rates decreased by 2% per year in white women and by 1% per year in African American women.
This summary is written and maintained by the PDQ Screening and Prevention Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.
  • Updated: April 6, 2018

No hay comentarios:

Publicar un comentario